Human Emotion. Machine Intelligence.
"Oncologists’ Current Perceptions and Utilization of Biomarker Testing for Newly-Diagnosed Non-Small Cell Lung Cancer Patients"
With the possible exception of breast cancer, biomarker testing is more established in non-small cell lung cancer (NSCLC) than in other oncology indications. If you believe that NSCLC biomarker testing is fully standardized, you would be wrong. Our survey respondents taught us that we are only at the end of the beginning of standardization of NSCLC biomarker testing.
Explore the following topics: